Cargando…

ТТГ-продуцирующая микроаденома гипофиза: проблемы диагностики в дебюте заболевания

Tumors of the pituitary gland producing thyrotropin hormone (TSH) are rare and account for about 1–3% of all pituitary adenomas, most frequently occurring in persons of young and working age. This article presents a clinical case of thyrotropinoma in a 44-year-old woman, which was diagnosed 6 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Климчук, А. В., Яцков, И. А., Бублей, К. В., Энзель, Д. А., Щербаков, А. С.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrinology Research Centre 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762533/
https://www.ncbi.nlm.nih.gov/pubmed/35841167
http://dx.doi.org/10.14341/probl12860
_version_ 1784852882185519104
author Климчук, А. В.
Яцков, И. А.
Бублей, К. В.
Энзель, Д. А.
Щербаков, А. С.
author_facet Климчук, А. В.
Яцков, И. А.
Бублей, К. В.
Энзель, Д. А.
Щербаков, А. С.
author_sort Климчук, А. В.
collection PubMed
description Tumors of the pituitary gland producing thyrotropin hormone (TSH) are rare and account for about 1–3% of all pituitary adenomas, most frequently occurring in persons of young and working age. This article presents a clinical case of thyrotropinoma in a 44-year-old woman, which was diagnosed 6 years after her initial visit to an endocrinologist. At the debut of the disease, thyrotropinoma manifested as an isolated elevation of TSH, with normal levels of free T4 and free T3. The patient was constantly taking β-blockers due to her disturbing tachycardia. She was diagnosed with subclinical hypothyroidism, for which she was periodically observed, controlling her TSH level and taking levothyroxine drugs in a dose of up to 175 mcg, which was accompanied by elevated TSH levels. After 6 years, there was an increase in free T3 and free T4 in addition to TSH. Magnetic resonance imaging with intravenous contrast enhancement revealed a pituitary microadenoma 4 mm in size, and laboratory examination of all tropic hormones revealed an isolated increase in TSH. Transsphenoidal adenomectomy was performed at the diagnosis of TSH-producing pituitary adenoma. During the three-year postoperative follow-up there was no adenoma recurrence, secondary hypothyroidism developed, the patient currently takes levothyroxine 75 mcg per day continuously
format Online
Article
Text
id pubmed-9762533
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Endocrinology Research Centre
record_format MEDLINE/PubMed
spelling pubmed-97625332023-01-06 ТТГ-продуцирующая микроаденома гипофиза: проблемы диагностики в дебюте заболевания Климчук, А. В. Яцков, И. А. Бублей, К. В. Энзель, Д. А. Щербаков, А. С. Probl Endokrinol (Mosk) Research Article Tumors of the pituitary gland producing thyrotropin hormone (TSH) are rare and account for about 1–3% of all pituitary adenomas, most frequently occurring in persons of young and working age. This article presents a clinical case of thyrotropinoma in a 44-year-old woman, which was diagnosed 6 years after her initial visit to an endocrinologist. At the debut of the disease, thyrotropinoma manifested as an isolated elevation of TSH, with normal levels of free T4 and free T3. The patient was constantly taking β-blockers due to her disturbing tachycardia. She was diagnosed with subclinical hypothyroidism, for which she was periodically observed, controlling her TSH level and taking levothyroxine drugs in a dose of up to 175 mcg, which was accompanied by elevated TSH levels. After 6 years, there was an increase in free T3 and free T4 in addition to TSH. Magnetic resonance imaging with intravenous contrast enhancement revealed a pituitary microadenoma 4 mm in size, and laboratory examination of all tropic hormones revealed an isolated increase in TSH. Transsphenoidal adenomectomy was performed at the diagnosis of TSH-producing pituitary adenoma. During the three-year postoperative follow-up there was no adenoma recurrence, secondary hypothyroidism developed, the patient currently takes levothyroxine 75 mcg per day continuously Endocrinology Research Centre 2022-03-09 /pmc/articles/PMC9762533/ /pubmed/35841167 http://dx.doi.org/10.14341/probl12860 Text en Copyright © Endocrinology Research Centre, 2022 https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 License.
spellingShingle Research Article
Климчук, А. В.
Яцков, И. А.
Бублей, К. В.
Энзель, Д. А.
Щербаков, А. С.
ТТГ-продуцирующая микроаденома гипофиза: проблемы диагностики в дебюте заболевания
title ТТГ-продуцирующая микроаденома гипофиза: проблемы диагностики в дебюте заболевания
title_full ТТГ-продуцирующая микроаденома гипофиза: проблемы диагностики в дебюте заболевания
title_fullStr ТТГ-продуцирующая микроаденома гипофиза: проблемы диагностики в дебюте заболевания
title_full_unstemmed ТТГ-продуцирующая микроаденома гипофиза: проблемы диагностики в дебюте заболевания
title_short ТТГ-продуцирующая микроаденома гипофиза: проблемы диагностики в дебюте заболевания
title_sort ттг-продуцирующая микроаденома гипофиза: проблемы диагностики в дебюте заболевания
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762533/
https://www.ncbi.nlm.nih.gov/pubmed/35841167
http://dx.doi.org/10.14341/probl12860
work_keys_str_mv AT klimčukav ttgproduciruûŝaâmikroadenomagipofizaproblemydiagnostikivdebûtezabolevaniâ
AT âckovia ttgproduciruûŝaâmikroadenomagipofizaproblemydiagnostikivdebûtezabolevaniâ
AT bublejkv ttgproduciruûŝaâmikroadenomagipofizaproblemydiagnostikivdebûtezabolevaniâ
AT énzelʹda ttgproduciruûŝaâmikroadenomagipofizaproblemydiagnostikivdebûtezabolevaniâ
AT ŝerbakovas ttgproduciruûŝaâmikroadenomagipofizaproblemydiagnostikivdebûtezabolevaniâ